Document is current
Any future updates will be listed below
-
Authors
Lasica, Aleksandra B.
Tang, Alice R.
Iqbal, Arooba
Nakhate, Vihang
Wen, Patrick Y.
- License Information
-
More Information
Article History
Received: 8 October 2025
Accepted: 4 February 2026
First Online: 24 March 2026
Declarations
:
: ABL – No conflicts of interest to declare; ART – No conflicts of interest to declare; AI – No conflicts of interest to declare; VN – Advisory Board: Servier Pharmaceuticals; PYW – Research Support: Astra Zeneca, Black Diamond, Bristol Meyers Squibb, Chimerix, Eli Lily, Erasca, Global Coalition For Adaptive Research, MediciNova, Merck, Nerviano, Novartis, Philogen, Quadriga, Servier; Advisory Board/Consultant: Alexion/Astra Zeneca, Black Diamond, Chimerix, Day One Bio, Fore Biotherapeutics, Genenta, Glaxo Smith Kline, Kintara, Merck, Nerviano, Nuvation Bio, Medical Sciences, Novartis, Novocure, Rigel, Sapience, Servier, Telix.
